1. Adjuvant 131I-metuximab in hepatocellular carcinoma: a new option for an old drug?. (June 2020) Authors: Vogel, Arndt; Saborowski, Anna Journal: Lancet gastroenterology and hepatology Issue: Volume 5:Number 6(2020) Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances in systemic therapy for the first-line treatment of unresectable HCC. Issue 6 (3rd June 2021) Authors: Vogel, Arndt; Bathon, Melanie; Saborowski, Anna Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 6(2021) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience. (February 2022) Authors: de Castro, Tiago; Jochheim, Leonie S.; Bathon, Melanie; Welland, Sabrina; Scheiner, Bernhard; Shmanko, Kateryna; Roessler, Daniel; Ben Khaled, Najib; Jeschke, Matthias; Ludwig, Johannes M.; Marquardt, Jens U.; Weinmann, Arndt; Pinter, Matthias; Lange, Christian M.; Vogel, Arndt; Saborowski, Anna Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence. (February 2023) Authors: Vogel, Arndt; Ochsenreither, Sebastian; Zager, Jonathan S.; Wacker, Frank; Saborowski, Anna Journal: Cancer treatment reviews Issue: Volume 113(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Corrigendum to "Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma" [Cancer Treatm. Rev. 82 (2019) 101946]. (February 2020) Authors: Vogel, Arndt; Saborowski, Anna Journal: Cancer treatment reviews Issue: Volume 83(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. (January 2020) Authors: Vogel, Arndt; Saborowski, Anna Journal: Cancer treatment reviews Issue: Volume 82(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma. (20th May 2019) Authors: Vicent, Silvestre; Lieshout, Ruby; Saborowski, Anna; Verstegen, Monique M. A.; Raggi, Chiara; Recalcati, Stefania; Invernizzi, Pietro; van der Laan, Luc J. W.; Alvaro, Domenico; Calvisi, Diego F.; Cardinale, Vincenzo Other Names: Calvisi Diego F. guestEditor. Journal: Liver international Issue: Volume 39(2019)Supplement 1 Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma. (20th May 2019) Authors: Vicent, Silvestre; Lieshout, Ruby; Saborowski, Anna; Verstegen, Monique M. A.; Raggi, Chiara; Recalcati, Stefania; Invernizzi, Pietro; van der Laan, Luc J. W.; Alvaro, Domenico; Calvisi, Diego F.; Cardinale, Vincenzo Other Names: Calvisi Diego F. guestEditor. Journal: Liver international Issue: Volume 39(2019)Supplement 1 Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FGFR inhibitors in cholangiocarcinoma: what's now and what's next?. (September 2020) Authors: Saborowski, Anna; Lehmann, Ulrich; Vogel, Arndt Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing. (6th June 2019) Authors: Mishra, Amrendra; Emamgholi, Fatemeh; Erlangga, Zulrahman; Hartleben, Björn; Unger, Kristian; Wolff, Katharina; Teichmann, Ulrike; Kessel, Michael; Woller, Norman; Kühnel, Florian; Dow, Lukas E; Manns, Michael P; Vogel, Arndt; Lowe, Scott W; Saborowski, Anna; Saborowski, Michael Journal: Carcinogenesis Issue: Volume 41:Number 3(2020) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗